Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Phosphoinositide 3-kinase (PI3K) inhibitor influencing CD43 by disrupting PI3K signaling, which can affect CD43 expression and cellular processes related to its function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor indirectly modulating CD43 by impacting downstream signaling pathways that influence CD43 expression and function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor influencing CD43 by disrupting PI3K signaling, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $156.00 $612.00 | 27 | |
Calmodulin inhibitor indirectly impacting CD43 by modulating calcium-dependent signaling pathways that influence CD43 expression and function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor influencing CD43 indirectly by modulating mTOR signaling, leading to alterations in CD43 expression and cellular processes related to its function. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibitor of NF-κB signaling indirectly influencing CD43 by disrupting NF-κB-mediated transcriptional regulation, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
AMP-activated protein kinase (AMPK) activator that indirectly modulates CD43 by influencing cellular energy status and downstream signaling pathways that impact CD43 expression and function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor indirectly influencing CD43 by disrupting the MAPK/ERK signaling pathway, leading to altered CD43 expression and cellular processes associated with CD43 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor indirectly modulating CD43 by disrupting p38 MAPK signaling, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK1/2 inhibitor indirectly impacting CD43 by disrupting the MAPK/ERK signaling pathway, leading to altered CD43 expression and modulation of cellular processes associated with CD43 function. | ||||||